Depot versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: A Cochrane Review

Human Reproduction

Volumn 18, Issue 10, 2003, Pages 2008-2017

  Albuquerque, L E T ^a,b,d   Saconato, H ^c   Maciel, M C R ^d   Baracat, E C ^a   Freitas, V ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital Perola Byington   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d Associacao para o Estudo da Fertil   (Brazil)

Author keywords

GnRH agonist daily injections; GnRH agonist depot; Pituitary desensitization; Randomized controlled trials

Indexed keywords

BUSERELIN ACETATE; DEXTRO TRIPTORELIN; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LONG ACTING DRUG; NAFARELIN; NOSE SPRAY; RECOMBINANT FOLLITROPIN; SHORT ACTING DRUG; TRIPTORELIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AMPOULE; ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DEPRESSION; DESENSITIZATION; EDEMA; EMBASE; ESTRUS CYCLE; FATIGUE; FERTILIZATION IN VITRO; GENETIC HETEROGENEITY; HEADACHE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; HYPOPHYSIS; INFERTILITY; INJECTION; INTRACYTOPLASMIC SPERM INJECTION; IRRITABILITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; NAUSEA; OUTCOMES RESEARCH; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 0142031059     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg333     Document Type: Article

References (47)

1. Bussenot, I., Azoulay-Barjonet, C. and Parianaud, J. (1993) Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs. J. Clin. Endocrinol. Metab., 76, 1376-1379.
2. Dada, T., Salha, O., Baillie, H.S. and Sharma, V. (1999) A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: A prospective randomized study. Hum. Reprod., 14, 288-293.
3. DalPrato, L., Borini, A., Trevisi, M.R., Bonu, M.A., Sereni, E. and Flamigni, C. (2001) Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: A randomized study. Hum. Reprod., 16, 1409-1414.
4. Daya, S. (1999) Long versus short gonadotropin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles. The Cochrane Library, issue 3, Update Software, Oxford.
5. DeMets, D.L. (1987) Methods for combining randomized clinical trials: Strengths and limitations. Stat. Med., 6, 341-350.
6. Devreker, F., Van Der Bergh, M., Govaerts, I., Gervy, C., Bertrand, E. and Englert, Y. (1996) The long-acting gonadotropin-releasing hormone analogues impaired the implantation rate. Fertil. Steril., 65, 122-126.
7. Devroey, P., Mannaerts, B., Smitz, J., Coelingh Bennink, H. and Van Steirteghem, A. (1994) Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum. Reprod., 1064-1069.
8. Dicker, D., Goldman, G.A., Ashkenazi, J., Feldberg, D., Shelef, M. and Goldman, J.A. (1991) Combination of long and short term GnRH analogue protocols: A new therapeutic approach to persistent high progesterone levels in IVF cycles. Hum. Reprod., 6, 203-205.
9. Dor, J., Bider, D., Shulman, A., Levron, J., Shine, S., Mashiach, S. et al. (2000) Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro - Results of a prospective, randomized in-vitro fertilization study. Hum. Reprod., 15, 1225-1230.
10. Fábregues, F., Balasch, J., Creus, M., Cívico, S., Carmona, F., Puerto, B. et al. (1998) Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program. Fertil. Steril., 70, 46-51.
11. Fleming, R. and Coutts, J.R.T. (1986) Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil. Steril., 45, 226-230.
12. Gaetje, R. (1994) Influence of gonadotrophin releasing hormone (GnRH) and a GnRH-agonist on granulosa cell steroidogenesis. Clin. Exp. Obstet. Gynecol., 21, 164-169.
13. Gerrero, H.E., Stein, P., Asch, R.H., De Fried, E.P. and Tesone, M. (1993) Effect of a gonodotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. Fertil. Steril., 59, 803-808.
14. Gianaroli, L., Ferraretti, A.P., Feliciani, E., Tabanelli, C., Magli, C. and Fortini, D. (1994) Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles. Hum. Reprod., 9, 220-225.
15. Gonen, Y., Dirnfeld, M., Goldman, S., Koifman, M. and Abramovici, H. (1991) The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; Decapeptyl) and gonadotropins versus short-acting GnRH-a (Buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF). J. In Vitro Fertil. Embryo Transf., 8, 254-259.
16. Harrison, R.F., Kondaveeti, U., Barry-Kinsella, C., Gordon, A., Drudy, L., Cottell, E. et al. (1994) Should gonadotropin-releasing hormone down-regulation therapy be routine inin vitro fertilization? Fertil. Steril., 62, 568-573.
17. Hazout, A., Ziegler, D., Cornel, C., Fernandez, H., Lelaidier, C. and Frydman, R. (1993) Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation. Fertil. Steril., 59, 596-600.
18. Herman, A., Ron-El, R., Golan, A., Nachum, H., Soffer, Y. and Caspi, E. (1992) Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone. Hum. Reprod., 7, 465-468.
19. Isler, V., Lunenfeld, E., Potashnik, G. and Levy, J. (1991) Ovarian stimulation concomitant with pituitary-ovarian axis suppression by different GnRH agonist. Int. J. Fertil., 36, 121-127.
20. Librati, C., Hocke, C., Filet, J.P., Papaxanthos, A., Mene, D., Dulucq, M.C. et al. (1996) Le type d'analogue de la GnRH utilisé au cours des protocoles longs en FIV peut-il influencer les taux de grossesse? Contracept. Fertil. Sex, 24, 762-766.
21. Lipitz, S., Ben-Rafael, Z., Dor, J., Shalev, J., Elenbogen, A., Levran, D. et al. (1989) Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: Comparison of three protocols. Gynecol. Obstet. Invest., 28, 31-34.
22. Lopes, A., Barriere, P., Charbonnel, B. and Paillard, B. (1986) Intérêt de l'utilisation brève d'un analogue de la gonadoreline dans un programme de Fécondation in vitro. Presse Med., 5, 2074.
23. Meldum, D.R., Wisot, A., Hamilton, F., Gutlay, A.L., Kempton, W. and Huynh, D. (1989) Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil. Steril., 51, 455-459.
24. Minaretzis, D., Jakubowski, M., Mortola, J. and Pavlou, S.N. (1995) Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J. Clin. Endocrinol. Metab., 80, 430-434.
25. Moher, D., Schulz, K.F. and Altman, D. (2001) The CONSORT statement: Revised recommendation for improving the quality of reports of parallel-group randomized trials. J. Am. Med. Assoc., 285, 1987-1991.
26. Néstor, J.J., Jr (1984) Development of agonistic LHRH analogs. In Vickery, B.H., Néstor, J.J., Jr and Hafez, E.S.E. (eds), LHRH and Its Analogs - Contraceptive and Therapeutic Applications. MTP Press, Lancaster, UK, pp. 3.
27. Oyesanya, O.A., Teo, S.K., Quah, E., Abdurazak, N., Lee, F.Y. and Cheng, W.C. (1995) Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: A comparison between a single dose of Zoladex depot and multiple daily doses of Suprefact. Hum. Reprod., 10, 1042-1044.
28. Parinaud, J., Beaur, A., Bourreau, E., Vieitez, G. and Pontonnier, G. (1988) Effect of a luteinizing hormone-releasing hormone agonist (buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil. Steril., 50, 597-602.
29. Parinaud, J., Oustry, P., Perineau, M., Rène, J.M., Monroziès, X. and Pontonnier, G. (1992) Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program. Fertil. Steril., 57, 1265-1268.
30. Peng, C., Fan, N.C., Ligier, M., Vaananen, J. and Leung, P.C. (1994) Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology, 135, 1740-1746.
31. Porcu, E., Fabbri, R., Dal Prato, L., Longhi, M., Seracchioli, R. and Flamigni, C. (1994) Comparison between depot and standard release triptoreline in in vitro fertilization: Pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results. Fertil. Steril., 62, 126-132.
32. Porcu, E., Filicori, M., Dal Prato, L., Fabbri, R., Seracchioli, R., Colombi, C. et al. (1995) Comparison between depot leuprorelin and daily buserelin in IVF. J. Assist. Reprod. Genet., 12, 15-19.
33. Porter, R.N., Smith, W. and Craft, I.L. (1984) Induction of ovulation for in vitro fertilisation using buserelin and gonadotrophins. Lancet, 2, 1284-1285.
34. Rabin, D. and McNeil, L.W. (1980) Pituitary and gonadal desensitization after continous luteinizing hormone-releasing hormone infusion in normal females. J. Clin. Endocrinol. Metab., 51, 873-876.
35. Ron-El, R., Herman, A., Golan, A., Soffer, Y., Nachum, H. and Caspi, E. (1992) Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone. Fertil. Steril., 58, 1164-1168.
36. Schmutzler, R.K., Reichert, C., Diedrich, K., Wildt, L., Diedrich, C.H., Al-Hasani, S. et al. (1988a) Vergleich eines langwirksamen und kurzwirksamen GnRH-Analogs in Kombination mit Gonadotropinen zur In-vitro-Fertilisierung unter verschiedenen Indikationsstellungen. Geburtshilfe Frauenheilkd., 49, 85-90.
37. Schmutzler, R.K., Reichert, C., Diedrich, K., Wildt, L., Diedrich, Ch., Al-Hasani, S. et al. (1988b) Combined GnRH-agonist/gonadotrophin stimulation for in-vitro fertilization. Hum. Reprod., 3, 29-33.
38. Tapanainen, J.S. and Hovatta, O. (1994) Pituitary down-regulation with goserelin (Zoladex) for in vitro fertilisation. Br. J. Obstet. Gynecol., 101, 27-28.
39. Tapanainen, J., Hovatta, O., Juntunen, K., Martikaineu, H., Ratsula, K., Tulppala, M, et al. (1993) Subcutaneous goserelin versus intranasal busererin for pituitary down-regulation in patients undergoing IVF: A randomized comparative study. Hum. Reprod., 8, 2052-2055.
40. Testart, J., Lefevre, B. and Gougeon, A. (1993) Effects of gonadotrophin releasing hormone agonists (GnRHa) on follicle and oocyte quality. Hum. Reprod., 8, 511-518.
41. Tsai, H.D., Chen, C.M., Lo, H.Y. and Chang, C.C. (1995) Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization. Hum. Reprod., 10, 2909-2912.
42. Uemura, T., Namiki, T., Kimura, A., Yanagisawa, T. and Minaguchi, H. (1994) Direct effects of gonadotropin-releasing hormone on the ovary in rats and humans. Horm. Res., 41, 7-13.
43. VanUem, J.F., Garcia, J.E., Liu, H.C. and Rosenwaks, Z. (1986) Clinical aspects with regard to the occurrence of an endogenous LH surge in gonadotropin induced normal menstrual cycles. J. In Vitro Fertil. Embryo Transf., 3, 345-349.
44. Vauthier, D. and Lefebvre, G. (1989) The use of gonadotropin-releasing hormone analogs for in vitro fertilization: Comparison between the standard form and long-acting formulation on D-Trp-6-luteinizing hormone-releasing hormone. Fertil. Steril., 51, 100-104.
45. Vickery, B.H. and Néstor, J.J. (1987) Luteinizing hormone-releasing hormone analogs: Development and mechanism of action. Semin. Reprod. Endocrinol., 5, 353.
46. Wong, J.M., Forrest, K.A., Snabes, M.C., Zhao, S.Z., Gersh, G.E. and Kennedy, S.H. (2001) Efficacy of nafarelin in assisted reproductive technology: A meta-analysis. Hum. Reprod. Update, 7, 92-101.
47. Yang, Y.S., Ho, H.N., Lien, Y.R., Hwang, J.L., Melinda, S., Lin, H.R. et al. (1991) The use of a long-acting gonadotropin-releasing hormone analog (D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs. J. Formosan Med. Assoc., 90, 1081-1085.